Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
Mears HV, Young GR, Sanderson T, Harvey R, Barrett-Rodger J, Penn R, Cowton V, Furnon W, De Lorenzo G, Crawford M, Snell DM, Fowler AS, Chakrabarti AM, Hussain S, Gilbride C, Emmott E, Finsterbusch K, Luptak J, Peacock TP, Nicod J, Patel AH, Palmarini M, Wall E, Williams B, Gandhi S, Swanton C, Bauer DLV. Mears HV, et al. Among authors: penn r. PLoS Biol. 2025 Jan 21;23(1):e3002982. doi: 10.1371/journal.pbio.3002982. eCollection 2025 Jan. PLoS Biol. 2025. PMID: 39836705 Free PMC article.
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
Shawe-Taylor M, Greenwood D, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Bazire J, Harvey R; Crick COVID Serology Pipeline Investigators, Legacy Investigators; Libri V, Kassiotis G, Gamblin S, Lewis NS, Williams B, Swanton C, Gandhi S, Carr EJ, Wu MY, Bauer DLV, Wall EC. Shawe-Taylor M, et al. Among authors: penn r. Lancet. 2024 Mar 23;403(10432):1133-1136. doi: 10.1016/S0140-6736(24)00316-7. Epub 2024 Mar 11. Lancet. 2024. PMID: 38484752 Free PMC article. No abstract available.
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
Russell TW, Townsley H, Hellewell J, Gahir J, Shawe-Taylor M, Greenwood D, Hodgson D, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Bazire J, Harvey R, Fowler AS, Miah M, Smith C, Miranda M, Bawumia P, Mears HV, Adams L, Hatipoglu E, O'Reilly N, Warchal S, Ambrose K, Strange A, Kelly G, Kjar S, Papineni P, Corrah T, Gilson R, Libri V, Kassiotis G, Gamblin S, Lewis NS, Williams B, Swanton C, Gandhi S, Beale R, Wu MY, Bauer DLV, Carr EJ, Wall EC, Kucharski AJ. Russell TW, et al. Among authors: penn r. Lancet Infect Dis. 2025 Jan;25(1):80-93. doi: 10.1016/S1473-3099(24)00484-5. Epub 2024 Sep 11. Lancet Infect Dis. 2025. PMID: 39276782 Free article.
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
Dowgier G, Hobbs A, Greenwood D, Shawe-Taylor M, Stevenson-Leggett P, Bazire J, Penn R, Harvey R; Crick COVID serology pipeline, Legacy Investigators; Libri V, Kassiotis G, Gamblin S, Lewis NS, Williams B, Swanton C, Gandhi S, Bauer DLV, Carr EJ, Wall EC, Wu MY. Dowgier G, et al. Among authors: penn r. Vaccine. 2025 Apr 30;54:126960. doi: 10.1016/j.vaccine.2025.126960. Epub 2025 Mar 7. Vaccine. 2025. PMID: 40056806 Free article.
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024.
Stevenson-Leggett P, Adams L, Greenwood D, Lofts A, Libri V, Williams B, Gandhi S, Swanton C, Gamblin S, Carr EJ, Harvey R, Lewis NS, Wu MY, Wall EC; Crick Neutralization Consortium; Legacy Investigators; Crick Neutralization Consortium and Legacy Investigators. Stevenson-Leggett P, et al. Emerg Infect Dis. 2025 Jun;31(6):1202-1206. doi: 10.3201/eid3106.241796. Emerg Infect Dis. 2025. PMID: 40439507 Free PMC article.
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.
Ahimbisibwe G, Greenwood D, Wilkinson KA, Gahir J, Townsley H, Miah M, Bawumia P, Chaloner C, Levi D, Hobson P, Riddell A, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Daley O, Bazire J, Harvey R, Fowler AS, Smith C, Miranda M, O'Reilly N, Warchal S, Ambrose K, Strange A, Kelly G, Kjar S; Legacy Investigators; Williams B, Libri V, Gamblin S, Gandhi S, Swanton C, Bauer DL, Wilkinson RJ, Carr EJ, Wall EC. Ahimbisibwe G, et al. Among authors: penn r. J Infect. 2025 Sep;91(3):106598. doi: 10.1016/j.jinf.2025.106598. Epub 2025 Aug 21. J Infect. 2025. PMID: 40848990 Free PMC article.
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.
Shawe-Taylor MJ, Greenwood D, He A, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Bazire J, Harvey R, Champsas D, Sharmin S, Aojula A, Bianchi A, Al-Araji S, Hacohen Y, Yam C, Mohamud S, Christensen R, Moccia M; Crick COVID Serology Pipeline; Legacy Investigators; Libri V, Kassiotis G, Gamblin S, Lewis N, Williams B, Swanton C, Gandhi S, Bauer D, Wu M, Carr E, Wall E, Ciccarelli O. Shawe-Taylor MJ, et al. Among authors: penn r. BMJ Neurol Open. 2025 Dec 16;7(2):e001210. doi: 10.1136/bmjno-2025-001210. eCollection 2025. BMJ Neurol Open. 2025. PMID: 41425831 Free PMC article.
543 results